Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALANCE-AAD-1
NCT06808984Phase 2Recruiting
- Sponsor
- Celgene Corporation
- Start
- Jun 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of bms-986368 in agitation, sponsored by Celgene Corporation. Started Jun 2025; status: recruiting.
02
Drugs
bms-986368
03
Conditions
agitation
Beyond the preview
Go deeper on NCT06808984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06808984.